Login / Signup

Mediators of ertugliflozin effects on heart failure and kidney outcomes among patients with type 2 diabetes mellitus.

Matthew W SegarAhmed A KolkailahRobert FrederichAnnpey PongChristopher P CannonFrancesco CosentinoSamuel Dagogo-JackDarren K McGuireRichard E PratleyChih-Chin LiuMario MaldonadoJie LiuNilo B CaterAmbarish PandeyDavid Z I Cherney
Published in: Diabetes, obesity & metabolism (2022)
NCT01986881.
Keyphrases
  • heart failure
  • left ventricular
  • atrial fibrillation
  • acute heart failure
  • cardiac resynchronization therapy
  • type diabetes
  • metabolic syndrome